Physician profile
Andrew Waller
NPI 1053334219
$1,058.87
in general payments reported to CMS, 2019-2025
8 companies · $610 in 2025
The $610 reported for 2025 was more than what 77% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23.76 · 2020: $20.86 · 2022: $19.42 · 2023: $240 · 2024: $145 · 2025: $610.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $995.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $994.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $228.23 | 2025 | Caplyta |
| Braeburn INC. | $207.50 | 2023-2025 | Brixadi |
| Electromed, INC. | $182.24 | 2023 | Smartvest |
| Indivior INC. | $172.67 | 2024-2025 | Sublocade |
| Abbvie INC. | $142.72 | 2022-2025 | |
| Gilead Sciences, INC. | $60.69 | 2023-2025 | |
| Allergan, INC. | $44.62 | 2019-2020 | |
| Uswm, LLC | $20.20 | 2024 | Lucemyra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Waller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.